Abstract
The effect of the anti-allergic drug disodium cromoglycate (DSCG) on immediate and late responses to anti-human IgE was examined in thirteen healthy subjects. DSCG, 250 micrograms, applied intradermally together with anti-IgE had no effect on the immediate flare and weal response, whereas the following late phase response, 1-24 hr, was attenuated by 15% (P less than 0.05, at 6 hr P less than 0.01). This effect varied between individuals (P less than 0.01) and was reproduced in a second trial in DSCG-responders and non-responders (P less than 0.01, n = 8). The results support the view that DSCG has no effect on the immediate mast cell derived response in human skin but can inhibit the development of late reactions. This mechanism might account for some of the anti-allergic effects of the drug.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
